v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Oct. 31, 2020
Nov. 02, 2019
Cash flows from operating activities:    
Net income $ 76.3 $ 31.7
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization expense 47.6 74.4
Deferred income tax provision (benefit) 0.0 (0.2)
Stock-based compensation expense 0.3 1.6
Impairment of tangible assets 10.2 0.7
Income from equity method investments (7.2) (19.0)
Non-cash interest expense 2.7 2.6
Non-cash right-of-use/lease liability amortization and terminations (167.4) 0.0
Gain on sale of intangible assets (38.9) (5.0)
Other non-cash income, net 0.5 (6.6)
Changes in operating assets and liabilities:    
Inventories (49.6) (124.9)
Accounts payable, accrued liabilities and income tax liabilities 96.3 26.7
Deferred income (4.1) 1.0
Operating lease right-of-use assets and lease liabilities (69.0) (11.4)
Other balance sheet changes, net (34.7) (13.3)
Cash flows used in operating activities (137.0) (41.7)
Cash flows from investing activities:    
Capital expenditures (2.9) (29.2)
Proceeds from sale of intangible assets 40.8 5.0
Cash flows provided by (used in) investing activities 37.9 (24.2)
Cash flows from financing activities:    
Proceeds from new term loan 312.3 0.0
Payments of term loan (162.3) 0.0
Repayments of revolver borrowings (230.0) 0.0
Payment of deferred financing costs (20.6) 0.0
Cash flows used in financing activities (100.6) 0.0
Net decrease in cash, cash equivalents and restricted cash (199.7) (65.9)
Cash, cash equivalents and restricted cash at beginning of period 581.6 329.2
Cash, cash equivalents and restricted cash at end of period $ 381.9 $ 263.3